Intrathecal meperidine for elective caesarean section: a comparison with lidocaine.
The purpose of this study was to determine the efficacy of intrathecal meperidine in patients undergoing Caesarean section, and also to compare meperidine with heavy lidocaine. Fifty full-term pregnant women, ASA physical status I or II, presenting for elective Caesarean section under spinal anaesthesia were randomly divided into two groups with 25 in each, to receive either intrathecal meperidine or lidocaine. All patients received premedication with oral ranitidine, 150 mg, the night before surgery, and again two hours before surgery. Patients in the meperidine group were also given metoclopramide iv 10 mg one hour before surgery. After iv 20 ml.kg-1 Ringer's lactate, patients were given either 5% meperidine 1 mg.kg-1 or 5% heavy lidocaine 1.2 to 1.4 ml intrathecally. The sensory and motor blockades in all except two patients in each group who required sedation at the time of skin incision were adequate for surgery. None of the mothers suffered from any major side effects. The incidence of hypotension was higher in the lidocaine group than in meperidine group (P < 0.05). Pruritus and drowsiness were more common in meperidine group than in lidocaine group (P < 0.01). All the newborns in both groups cried immediately after birth and had an Apgar score > 7. The mean duration of postoperative analgesia was six hours in the meperidine group and one hour in the lidocaine group (P < 0.01). Postoperative analgesia requirement was less in the meperidine than in the lidocaine group (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Kafle
S K
SK
Department of Anaesthesiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
D000328:Adult; D016362:Analgesia, Obstetrical; D000767:Anesthesia, Epidural; D001034:Apgar Score; D002585:Cesarean Section; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D007278:Injections, Spinal; D007431:Intraoperative Complications; D008012:Lidocaine / Q000008:administration & dosage* / Q000009:adverse effects; D008614:Meperidine / Q000008:administration & dosage* / Q000009:adverse effects; D008787:Metoclopramide / Q000008:administration & dosage; D009132:Muscles / Q000187:drug effects; D011247:Pregnancy; D011537:Pruritus / Q000139:chemically induced; D012677:Sensation / Q000187:drug effects; D012894:Sleep Stages / Q000187:drug effects; D013997:Time Factors
D008012:Lidocaine; D008614:Meperidine; D008787:Metoclopramide